Koh, Y., Lee, H., Im, S., Kim, S., Kim, T., Han, S., … Bang, Y. (1969). VEGF Expression is Related to Good Response and Long Progression-free Survival in Gastrointestinal Stromal Tumor Patients Treated With Sunitinib. Diagnostic Molecular Pathology : The American Journal of Surgical Pathology, Part B. https://doi.org/10.1097/PDM.0b013e3182107ea0 (Original work published)

Turner, N., Finn, R., Martin, M., Im, S., DeMichele, A., Ettl, J., … Gelmon, K. (2018). Clinical Considerations of the Role of Palbociclib in the Management of Advanced Breast Cancer Patients With and Without Visceral Metastases. Annals of Oncology : Official Journal of the European Society for Medical Oncology. https://doi.org/10.1093/annonc/mdx797 (Original work published 2018)

Pivot, X., Bondarenko, I., Nowecki, Z., Dvorkin, M., Trishkina, E., Ahn, J., … Lim, J. (2018). Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive... Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2017740126. https://doi.org/10.1200/JCO.2017.74.0126 (Original work published 2018)

Kim, S., Dent, R., Im, S., Espié, M., Blau, S., Tan, A., … LOTUS, investigators. (2017). Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet. Oncology, 18(10), 1360-1372. https://doi.org/10.1016/S1470-2045(17)30450-3